News About: Pharm. Industry
Small- and medium-sized companies should be exposed to new technology
Domestic small- and medium-sized drug makers should focus on research and development of new drugs to survive in an era of the free trade agreements, experts said.
These firms should pursue the knowledge-intensive...
Sewon Cellontech makes 12.2 billion plant export deal
Sewon Cellontech said on November 9 it signed an agreement with Australia based Kellogg Joint Venture Gorgon to export its column in the Gorgon LNG Project. The column is a vertical type equipment and designed with lo...
Two pharmaceutical firms launch antidiabetic campaign in Dokdo
Handok Pharm and Novartis Korea launched an antidiabetic campaign in Dokdo, emphasizing a similar movement to protect pancreatic islet cell in the treatment of diabetes.
Located roughly halfway between Korea and Ja...
Boryung opens synthesis plant for Fimasartan
Boryung Pharm has completed its synthesis plant for Fimasartan, antihypertensive agent, at Ansan of Kyunggi Province.
A completion ceremony was held on November 6, 14 months after the ground was broken last August....
Sales of Yuyu’s nasal wash continues to rise
Sales of Physiomer jumped in the domestic nasal wash market thanks to intensive marketing activities via mass media and public campaign, according to Yuyu Pharm.
The company said Physiomer has a bigger market share...
Small- and medium-sized pharmaceutical firms eager to recruit QA managers
A good is in store for quality assurance managers, as small- and medium-sized pharmaceutical companies are rushing to recruit them in the era of the Current Good Manufacturing Practice (cGMP) system.
“A QA expert ...
Pfizer Korea to offer R&D training program for university students
The third research and development (R&D) training program for local university students will take place between November 11 and 21 in Seoul, Daegu and Pusan to foster globally competitive talents.
Under the main th...
Green Cross says adjuvant promising in new flu vaccine
Green Cross Corporation, a local drug maker responsible for the domestic production of the flu vaccine, said that its new vaccine with an adjuvant demonstrated excellent antibody-producing effects against the H1N1 flu...
Concerns rise among Korean drug makers
The domestic pharmaceutical sector is expected to face an inevitable blow under the government’s scheme to cut drug prices as part of its efforts to stamp out illegal rebate provisions.
Prospects have been grim for...
Dong-A to conduct phase 3 study for Zydena in US
Dong-A Pharmaceutical Co., says it will carry out its Phase 3 multicenter study in the United States, designed to investigate the efficacy and safety of Zydena (udenafil) in 1,120 patients with erectile dysfunction af...
